These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1950916)

  • 1. Optimal use of MR contrast agents: how much is enough?
    Maravilla KR
    AJNR Am J Neuroradiol; 1991; 12(5):881-3. PubMed ID: 1950916
    [No Abstract]   [Full Text] [Related]  

  • 2. Sonographic guidance of needle position for MR arthrography of the shoulder.
    Valls R; Melloni P
    AJR Am J Roentgenol; 1997 Sep; 169(3):845-7. PubMed ID: 9275909
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of bolus and constant infusion methods of gadolinium administration in MR angiography.
    Sze G; Goldberg SN; Kawamura Y
    AJNR Am J Neuroradiol; 1994 May; 15(5):909-12. PubMed ID: 8059659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 8. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approval from the Food and Drug Administration for unapproved use of an approved drug or device.
    Bates BF
    AJR Am J Roentgenol; 1994 Sep; 163(3):748; author reply 748-9. PubMed ID: 8079894
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized seizure after i.v. administration of gadopentetate dimeglumine.
    Harbury OL
    AJNR Am J Neuroradiol; 1991; 12(4):666. PubMed ID: 1882740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound.
    Bednarski MD; Lee JW; Callstrom MR; Li KC
    Radiology; 1997 Jul; 204(1):263-8. PubMed ID: 9205257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral contrast media in the study of the esophagus with magnetic resonance. Proposal of a new preparation].
    Squillaci E; Fanucci E; Crecco M; Grandinetti ML; Cecconi L; Squillaci S; Simonetti G; Mattioli M; Vitali L
    Radiol Med; 1992 Dec; 84(6):761-6. PubMed ID: 1494679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
    Alhassan A; Weinmann HJ
    AJNR Am J Neuroradiol; 1997 Apr; 18(4):785-6; author reply 786-8. PubMed ID: 9127052
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications.
    Winalski CS; Aliabadi P; Wright RJ; Shortkroff S; Sledge CB; Weissman BN
    Radiology; 1993 Apr; 187(1):179-85. PubMed ID: 8451409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A choroid plexus papilloma arising from an incidental pineal cyst.
    Steven DA; McGinn GJ; McClarty BM
    AJNR Am J Neuroradiol; 1996 May; 17(5):939-42. PubMed ID: 8733971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhancement of normal intervertebral disks: time and dose dependence.
    Ibrahim MA; Jesmanowicz A; Hyde JS; Estkowski L; Haughton VM
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):419-23. PubMed ID: 8197936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadopentetate dimeglumine and iodinated contrast media. Hemodynamic side effects after bolus injections in pigs.
    Kuhtz-Buschbeck JP; Ehrhardt K; Köhnlein S; Radtke W; Heintzen P
    Invest Radiol; 1997 Feb; 32(2):111-9. PubMed ID: 9039584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.